Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q1 2026 Earnings

26FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.38

-0.35

-0.31

-0.27

Details

Expected EPS

-0.27044

Actual EPS

-0.27

Surprise EPS

0

Surprise Percent

+0.16%

Description

Fate Therapeutics (FATE) has reported earnings of -0.27 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.